GS
HOOK

Gilead Sciences’s HOOKIPA Pharma HOOK Stock Holding History

Gilead Sciences’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,875,945
Closed -$2.35M – 12
2025
Q2 		$2.35M Hold
1,875,945
– – 0.18% 9
2025
Q1 		$2.03M Hold
1,875,945
– – 0.17% 10
2024
Q4 		$3.77M Buy
+1,875,945
New +$5.8M 0.24% 11

Other funds holding HOOK

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Gilead Sciences's HOOK Position: Q3 2025 in Review

Gilead Sciences sold out of HOOKIPA Pharma (HOOK) in Q3 2025, closing a stake of 1,875,945 shares — an estimated $2.35M sold.

Gilead Sciences first reported a position in HOOK in Q4 2024 and held it in 3 quarters. The position peaked at $3.77M in Q4 2024. 6 funds tracked by Wall St. Rank hold HOOK as of Q3 2025.

  • Gilead Sciences reported no remaining HOOKIPA Pharma position as of Q3 2025 after selling out during the quarter.
  • Gilead Sciences sold 1,875,945 HOOKIPA Pharma shares in Q3 2025, an estimated $2.35M.
  • Gilead Sciences first reported a position in HOOKIPA Pharma in Q4 2024 and held it in 3 quarters.
  • Gilead Sciences's HOOKIPA Pharma position peaked at $3.77M in Q4 2024.
  • 6 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2025.

Based on Gilead Sciences's 13F filing for Q3 2025, filed 13 Nov 2025.